You have 9 free searches left this month | for more free features.

Atezolizumab

Showing 551 - 575 of 765

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Solid Tumors Trial in Worldwide (Atezolizumab, Selicrelumab)

Completed
  • Solid Tumors
  • Philadelphia, Pennsylvania
  • +10 more
Dec 11, 2019

Solid Tumors Trial in Worldwide (Atezolizumab, RO6958688)

Completed
  • Solid Tumors
  • Santa Monica, California
  • +23 more
Feb 10, 2020

Solid Tumors Trial in Worldwide (Atezolizumab, Cergutuzumab Amunaleukin)

Completed
  • Solid Tumors
  • Atezolizumab
  • Cergutuzumab Amunaleukin
  • New Haven, Connecticut
  • +13 more
Jan 15, 2020

Colorectal Tumors Trial in United States (GRT-C901, GRT-R902, Atezolizumab)

Recruiting
  • Colorectal Neoplasms
  • Gilbert, Arizona
  • +46 more
Jan 31, 2023

DLBCL, Not Otherwise Specified Trial in Amsterdam, Groningen (89Zr-atezolizumab PET scans)

Recruiting
  • Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
  • 89Zr-atezolizumab PET scans
  • Amsterdam, Noord-Holland, Netherlands
  • +1 more
Jun 14, 2019

Lung Cancer Trial in Shanghai (chemo plus TCM 1&ICIs plusTCM2 , chemo plus TCM 1 &ICIs plus TCM2 )

Not yet recruiting
  • Lung Cancer
  • chemotherapy plus TCM 1&ICIs plusTCM2 placebo
  • chemotherapy plus TCM 1placebo &ICIs plus TCM2 placebo
  • Shanghai, Shanghai, China
    YueYang Hosptial of Intergrated Traditional Chinese and Western
Apr 17, 2023

Metastatic Breast Adenocarcinoma, Metastatic HER2-Positive Breast Carcinoma, Recurrent Breast Adenocarcinoma Trial in Canada,

Recruiting
  • Breast Adenocarcinoma
  • +8 more
  • Atezolizumab
  • +6 more
  • Birmingham, Alabama
  • +667 more
Apr 6, 2022

NSCLC, Squamous Cell Carcinoma of the Head and Neck Trial in Lexington (Immune checkpoint inhibitor, Radiation Therapy)

Recruiting
  • Non-small Cell Lung Cancer
  • Squamous Cell Carcinoma of the Head and Neck
  • Immune checkpoint inhibitor
  • Radiation Therapy
  • Lexington, Kentucky
    University of Kentucky Markey Cancer Center
Nov 10, 2022

Advanced Unresectable or Metastatic Solid Malignancy Trial in United States (Entrectinib, Inavolisib, Alectinib)

Recruiting
  • Advanced Unresectable or Metastatic Solid Malignancy
  • Birmingham, Alabama
  • +50 more
Aug 10, 2022

Ovarian Cancer Trial in Worldwide (Ipatasertib, Cobimetinib, Trastuzumab Emtansine)

Recruiting
  • Ovarian Cancer
  • Tucson, Arizona
  • +60 more
Jan 20, 2023

Atezolizumab Combination Therapy in Lung Cancer (J-TAIL-2)

Recruiting
  • Non-small Cell Lung Cancer
  • Extensive Disease Small Cell Lung Cancer
    • Akashi, Japan
    • +147 more
    Jun 23, 2021

    Solid Tumors Trial in Worldwide (Atezolizumab, Cobimetinib)

    Completed
    • Solid Tumors
    • Palo Alto, California
    • +20 more
    Dec 16, 2019

    Solid Tumor, Lymphoma Trial in Chicago, Morristown (Ad-p53)

    Unknown status
    • Solid Tumor
    • Lymphoma
    • Chicago, Illinois
    • +2 more
    Jun 5, 2020

    NSCLC, Colorectal Cancer, Advanced Solid Tumors Trial in Worldwide (GDC-6036, Atezolizumab, Cetuximab)

    Recruiting
    • Non-Small Cell Lung Cancer
    • +2 more
    • Duarte, California
    • +68 more
    Jan 10, 2023

    Liver Cancer Trial in Kansas City (Stereotactic Body Radiation Treatment)

    Not yet recruiting
    • Liver Cancer
    • Stereotactic Body Radiation Treatment
    • Kansas City, Kansas
      University of Kansas Medical Center
    Feb 13, 2023

    Solid Tumor Trial in Worldwide (Atezolizumab)

    Terminated
    • Solid Tumor
    • Atezolizumab
    • Little Rock, Arkansas
    • +29 more
    Feb 24, 2020

    Solid Tumor Trial in Worldwide (Atezolizumab, GDC-0919)

    Completed
    • Solid Tumor
    • Scottsdale, Arizona
    • +17 more
    Oct 18, 2019

    Cancer of Unknown Primary Site Trial in Worldwide (Alectinib, Vismodegib, Ipatasertib)

    Active, not recruiting
    • Cancer of Unknown Primary Site
    • Blacktown, New South Wales, Australia
    • +140 more
    Jan 6, 2023

    Polish Microbiome Map

    Unknown status
    • Melanoma
    • +4 more
    • Collection of stool samples
    • Poznań, Poland
      The Institute of Bioorganic Chemistry, Polish Academy of Science
    Nov 19, 2019

    Castrate-Resistant Prostate Cancer Trial in United States (Atezolizumab, Radium-223 Dichloride)

    Completed
    • Castrate-Resistant Prostate Cancer
    • Atezolizumab
    • Radium-223 Dichloride
    • Duarte, California
    • +16 more
    Sep 23, 2019

    Advanced Solid Tumors, Kirsten Rat Sarcoma (KRAS) pG12C Mutation Trial in Worldwide (Sotorasib, AMG 404, trametinib)

    Recruiting
    • Advanced Solid Tumors
    • Kirsten Rat Sarcoma (KRAS) pG12C Mutation
    • Tucson, Arizona
    • +83 more
    Dec 28, 2022

    Cholangiocarcinoma Non-resectable, Cholangiocarcinoma, Intrahepatic, Cholangiocarcinoma, Extrahepatic Trial in Korea, Republic

    Terminated
    • Cholangiocarcinoma Non-resectable
    • +3 more
    • Phoenix, Arizona
    • +35 more
    Jan 24, 2020

    Rectal Cancer Stage, Oesophageal Cancer Trial in Vienna (CRT, SCPRT, CROSS Protocol)

    Not yet recruiting
    • Rectal Cancer Stage
    • Oesophageal Cancer
    • CRT
    • +3 more
    • Vienna, Austria
      Medical University of Vienna
    Mar 26, 2022

    MDS Trial in United States (Atezolizumab, Azacitidine)

    Completed
    • Myelodysplastic Syndromes
    • Duarte, California
    • +14 more
    Aug 15, 2019

    Solid Tumor, Adult Trial in United States (FT538, Cyclophosphamide, Fludarabine)

    Recruiting
    • Solid Tumor, Adult
    • Hackensack, New Jersey
    • +3 more
    Apr 14, 2022